Microbiotica
Microbiotica is developing rationally designed living biotherapeutics products that modulate the gut microbiota for the treatment of human disease. The company’s discovery platform (Precision Metagenomics) has the potential to be exploited in many fields, including inflammatory bowel disease and oncology.